Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1858)
AN2 Therapeutics, Inc. (ANTX)
Eizen Joshua M — Chief Operating Officer and Chief Legal Officer
Shares
5,945
Price
$4.17
Total Value
$24.80K
Shares Held After
206,554
% of Holdings
2.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,500
Price
$0.97
Total Value
$5.33K
Shares Held After
367,485
% of Holdings
1.5%
Seer, Inc. (SEER)
Nishar Dipchand — Director
Shares
10,660
Price
$2.18
Total Value
$23.27K
Shares Held After
59,044
% of Holdings
15.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
1,015
Price
$16.00
Total Value
$16.24K
Shares Held After
135,202
% of Holdings
0.7%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
300
Price
$73.69
Total Value
$22.11K
Shares Held After
492,012
% of Holdings
0.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$302.46
Total Value
$200.83K
Shares Held After
0
% of Holdings
100.0%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
2,137
Price
$59.47
Total Value
$127.09K
Shares Held After
167,763
% of Holdings
1.3%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
3,477
Price
$58.55
Total Value
$203.58K
Shares Held After
169,900
% of Holdings
2.0%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
13,686
Price
$57.37
Total Value
$785.17K
Shares Held After
173,377
% of Holdings
7.3%
Tempus AI, Inc. (TEM)
Fukushima Ryan — CEO, Data
Shares
13,984
Price
$56.80
Total Value
$794.29K
Shares Held After
187,063
% of Holdings
7.0%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
830
Price
$30.31
Total Value
$25.16K
Shares Held After
129,855
% of Holdings
0.6%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
4,413
Price
$29.82
Total Value
$131.62K
Shares Held After
130,685
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
22,757
Price
$28.60
Total Value
$650.90K
Shares Held After
135,098
% of Holdings
14.4%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
1,075
Price
$30.35
Total Value
$32.63K
Shares Held After
182,177
% of Holdings
0.6%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,306
Price
$29.80
Total Value
$128.30K
Shares Held After
183,252
% of Holdings
2.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
22,833
Price
$28.76
Total Value
$656.65K
Shares Held After
187,558
% of Holdings
10.9%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
77
Price
$39.99
Total Value
$3.08K
Shares Held After
208,198
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,399
Price
$39.53
Total Value
$55.30K
Shares Held After
208,275
% of Holdings
0.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
105
Price
$39.99
Total Value
$4.20K
Shares Held After
209,674
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,906
Price
$39.53
Total Value
$75.34K
Shares Held After
209,779
% of Holdings
0.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
63
Price
$39.99
Total Value
$2.52K
Shares Held After
179,391
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
1,143
Price
$39.53
Total Value
$45.18K
Shares Held After
179,454
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
106
Price
$39.99
Total Value
$4.24K
Shares Held After
222,357
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,930
Price
$39.53
Total Value
$76.29K
Shares Held After
222,463
% of Holdings
0.9%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
4,200
Price
$28.75
Total Value
$120.74K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
4,371
Price
$28.71
Total Value
$125.48K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
30,000
Price
$27.94
Total Value
$838.14K
Shares Held After
4,200
% of Holdings
87.7%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
30,829
Price
$27.95
Total Value
$861.74K
Shares Held After
4,371
% of Holdings
87.6%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
14,800
Price
$27.13
Total Value
$401.48K
Shares Held After
35,200
% of Holdings
29.6%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
15,800
Price
$27.13
Total Value
$428.68K
Shares Held After
34,200
% of Holdings
31.6%
NEUROCRINE BIOSCIENCES INC (NBIX)
Delaet Ingrid — Chief Regulatory Officer
Shares
2,737
Price
$178.54
Total Value
$488.67K
Shares Held After
16,225
% of Holdings
14.4%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
18,531
Price
$3.52
Total Value
$65.23K
Shares Held After
52,274
% of Holdings
26.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,035
Price
$80.19
Total Value
$82.99K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
888
Price
$79.28
Total Value
$70.40K
Shares Held After
768,815
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$560.79
Total Value
$179.45K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
220
Price
$558.78
Total Value
$122.93K
Shares Held After
40,833
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
702
Price
$557.82
Total Value
$391.59K
Shares Held After
41,053
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$556.64
Total Value
$210.97K
Shares Held After
41,755
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
291
Price
$555.75
Total Value
$161.72K
Shares Held After
42,134
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,118
Price
$554.45
Total Value
$619.88K
Shares Held After
42,425
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,710
Price
$553.42
Total Value
$946.35K
Shares Held After
43,543
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,490
Price
$552.51
Total Value
$823.24K
Shares Held After
45,253
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
925
Price
$551.56
Total Value
$510.19K
Shares Held After
46,743
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
785
Price
$550.45
Total Value
$432.10K
Shares Held After
47,668
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
923
Price
$549.52
Total Value
$507.21K
Shares Held After
48,453
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
637
Price
$548.62
Total Value
$349.47K
Shares Held After
49,376
% of Holdings
1.3%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
1,100
Price
$6.13
Total Value
$6.74K
Shares Held After
1,482,587
% of Holdings
0.1%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
2,384
Price
$4.68
Total Value
$11.16K
Shares Held After
2,832,598
% of Holdings
0.1%
Syndax Pharmaceuticals Inc (SNDX)
Metzger Michael A — Director
Shares
32,375
Price
$24.24
Total Value
$784.78K
Shares Held After
484,843
% of Holdings
6.3%
Medtronic plc (MDT)
Walter Matthew R. — SVP, Chief HR Officer
Shares
3,102
Price
$83.15
Total Value
$257.93K
Shares Held After
35,694
% of Holdings
8.0%
Showing 1–50 of 1858 transactions (page 1 of 38)